Red wine compound injected into gums to fight periodontitis

NCT ID NCT07397026

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests whether injecting resveratrol nanoparticles into the gums can improve treatment for stage III periodontitis. 48 adults will receive either the resveratrol gel, a placebo, or standard deep cleaning alone. Researchers will measure gum attachment levels and inflammatory markers after 3 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
resveratrol loaded nanoparticles
What this could lead to
If it works, this could point toward a new gum disease treatment that reduces inflammation and improves healing.
What could go wrong
This is a very early phase 1 trial with only 48 people. It is too small to prove effectiveness, and resveratrol may not work better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIODONTITIS STAGE III are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of dentistry , Mansoura university

    Al Mansurah, DK, 35516, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.